Kia America has announced pricing for the 2026 Niro HEV, continuing its commitment to sustainable mobility solutions and innovative design. Built for drivers who want versatility and efficiency without sacrificing comfort or technology, the 2026 Niro HEV offers a purposeful driving experience with helpful connectivity, thoughtful interior materials and a functionally minded CUV format.
| Pricing – MSRP (excludes $1,445 destination)1 | |
| 2026 Niro HEV LX | $27,090 |
| 2026 Niro HEV EX | $29,890 |
| 2026 Niro HEV SX | $33,090 |
| 2026 Niro HEV SX Touring | $35,490 |
Powertrain and Efficiency:
All trims are powered by a 1.6-liter GDI four-cylinder engine paired with a 32kW electric motor, delivering a combined 139 horsepower and 195 pound-feet of torque. The 2026 Niro HEV is rated at a Kia-estimated 53 MPG combined2 for LX, EX and SX trims.
Technology:
Standard features include several of Kia’s suite of ADAS features3, such as Forward Collision-Avoidance Assist, Lane Keeping Assist, and Blind-Spot Collision Warning. Available features include Navigation-Based Smart Cruise Control4 and Highway Driving Assist5.
Click below for more information about the 2026 Niro HEV:
1 MSRP excludes destination and handling, taxes, title, license fees, options and retailer charges. Actual prices set by retailer and may vary.
2 Not official EPA estimates. Actual mileage will vary with options, driving conditions, driving habits and your vehicle’s condition.
3 Advanced driver assistance systems are not substitutes for safe driving and may not detect all objects around the vehicle. Always drive safely and use caution.
4 When engaged, Navigation-based Smart Cruise Control is not a substitute for safe driving and cruise-control procedures. This is not an auto-pilot feature. It may not detect every object around the vehicle. Always drive safely and use caution
5 When engaged, Highway Driving Assist is not a substitute for safe driving, may not detect all objects around the vehicle, and only functions on certain federal highways. Always drive safely and use caution
Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…
NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…
Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…
Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…
Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…
Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans…